Mexico Authorizes Lenacapavir, Six-Monthly Injection to Prevent HIV
20 Articles
20 Articles
Cofepris authorizes medical registration in Mexico of Lenapavir, important HIV prophylaxis
Cofepris gave the green light to the Lenacapavir health registry, a long-acting antiretroviral that can be administered for HIV prevention.
"Cofepris endorses its commitment to the protection of public health through the rigorous evaluation of new treatment alternatives for the prevention and care of diseases", externó
Mexico authorizes lenacapavir, six-monthly injection to prevent HIV
Lenacapavir already has a health record in Mexico. Know what this medicine is, how it works, and why it represents a new alternative to HIV.
The health authority detailed that the approval was issued as a result of the analysis of the quality and efficacy of the drug
Coverage Details
Bias Distribution
- 38% of the sources lean Left, 37% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
